Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Ettinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Harris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

Cummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J. A., Downs, R. W., Dequeker, J., Favus, M. J., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,276

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

Garnero, P., Hausherr, E., Chapuy, M. C., Marcelli, C., Grandjean, H., Müller, C., Cormier, C., Bréart, G., Meunier, P. J., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 984

Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P. D., Woodson, G. C., Yanover, M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 947

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years

Bruyère, O., Collette, J., Rizzoli, R., Decock, C., Ortolani, S., Cormier, C., Detilleux, J., & Reginster, J.-Y. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1078-8 · Cited by 33

Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients

Tanaka, S., Narusawa, K., Onishi, H., Miura, M., Hijioka, A., Kanazawa, Y., Nishida, S., Ikeda, S., & Nakamura, T. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1328-9 · Cited by 36

Postmenopausal women treated with combination parathyroid hormone (1–84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS)

Schafer, A. L., Burghardt, A. J., Sellmeyer, D. E., Palermo, L., Shoback, D., Majumdar, S., & Black, D. M. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2349-y · Cited by 32

Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)

Jakob, F. J. (2006) · QJM · doi:10.1093/qjmed/hcl073 · Cited by 32

Steps for targeting exercise towards the skeleton to increase bone strength.

Warden, S. J., Fuchs, R. K., & Turner, C. H. (2004) · PubMed · Cited by 32

Understanding compliance issues for daily self-injectable treatment in ambulatory care settings.

Brod, M. I., Rousculp, M. D., & Cameron, A. (2008) · PubMed Central · Cited by 32

Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models

Nazarian, A., Cory, E., Müller, R., & Snyder, B. D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0632-0 · Cited by 32

Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease

Majima, T., Komatsu, Y., Doi, K., Takagi, C., Shigemoto, M., Fukao, A., Morimoto, T., Corners, J., & Nakao, K. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0655-y · Cited by 32

The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study

Leung, J. Y., Ho, A. Y. Y., Ip, T., Lee, G., & Kung, A. W. C. (2005) · Bone · doi:10.1016/j.bone.2004.10.014 · Cited by 33

Skeletal fragility definition.

Leali, P. T., Muresu, F., Melis, A., Ruggiu, A., Zachos, A., & Doria, C. (2011) · PubMed Central · Cited by 31

Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review

Dusdal, K., Grundmanis, J., Luttin, K., Ritchie, P., Rompre, C., Sidhu, R., & Harris, S. R. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1497-6 · Cited by 31

Evaluation and Treatment of Osteoporosis

O’Connor, K. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.03.016 · Cited by 30

Follow-up Bone Mineral Density Testing: 2023 Official Positions of the International Society for Clinical Densitometry

Gani, L. U., Sritara, C., Blank, R. D., Chen, W., Gilmour, J., Dhaliwal, R., & Gill, R. S. (2023) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2023.101440 · Cited by 34

Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate

Miller, P. D., Delmas, P. D., Huss, H., Patel, K., Schimmer, R. C., Adami, S., & Recker, R. R. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9403-y · Cited by 30

Osteopenia and Osteoporosis in Female Athletes

MacKnight, J. M. (2017) · Clinics in Sports Medicine · doi:10.1016/j.csm.2017.05.006 · Cited by 30

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

(2006) · Europe PMC (PubMed Central) · Cited by 30

NCCN Task Force Report: Bone Health and Cancer Care

Theriault, R. L., Biermann, J. S., Brown, E., Brufsky, A., Demers, L. M., Grewal, R. K., Guise, T. A., Jackson, R. D., McEnery, K. W., Podoloff, D. A., et al. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.2002 · Cited by 30

The Effect of Antiresorptives on Bone Quality

Recker, R. R., & Armas, L. A. G. (2011) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-011-1909-8 · Cited by 29

Bone marrow stromal cell therapy improves femoral bone mineral density and mechanical strength in ovariectomized rats

Uejima, S., Okada, K., Kagami, H., Taguchi, A., & Ueda, M. (2008) · Cytotherapy · doi:10.1080/14653240802071616 · Cited by 29

Vertebral Fracture Risk Is Reduced in Women Who Lose Femoral Neck BMD With Teriparatide Treatment

Watts, N. B., Miller, P. D., Kohlmeier, L., Sebba, A. I., Chen, P., Wong, M., & Krohn, K. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081256 · Cited by 29

The Relationship Between Regional Bone Turnover Measured Using 18F-fluoride Positron Emission Tomography and Changes in BMD Is Equivalent to That Seen for Biochemical Markers of Bone Turnover

Frost, M. L., Cook, G., Blake, G. M., Marsden, P. K., & Fogelman, I. (2006) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2006.10.006 · Cited by 29

An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®

Kaufman, J.-M., Palacios, S., Silverman, S. L., Sutradhar, S., & Chines, A. A. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2341-6 · Cited by 29

Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: A study with odanacatib treatment in the ovariectomized adult rhesus monkey

Jayakar, R. Y., Cabal, A., Szumiloski, J., Sardesai, S., Phillips, E. A., Laib, A., Scott, B. B., Pickarski, M., Duong, L. T., Winkelmann, C. T., et al. (2012) · Bone · doi:10.1016/j.bone.2012.03.017 · Cited by 29

Apoptosis of Bone Cells

Jilka, R. L., Bellido, T., Almeida, M., Plotkin, L. I., O’Brien, C. A., Weinstein, R. S., & Manolagas, S. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00032-x · Cited by 30

Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data

Bell, K., Hayen, A. D., Glasziou, P., Irwig, L., Eastell, R., Harrison, S. L., Black, D. M., & Bauer, D. C. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2847 · Cited by 30

Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis

Camacho, P. M., & Lopez, N. A. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.310 · Cited by 29

Cortical bone quality affectations and their strength impact analysis using holographic interferometry

Ruiz, C. G. T., Torre-Ibarra, M. H. D. L., Flores‐Moreno, M., Frausto‐Reyes, C., & Santoyo, F. M. (2018) · Biomedical Optics Express · doi:10.1364/boe.9.004818 · Cited by 28

The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality

Karsdal, M. A., Byrjalsen, I., Leeming, D. J., Delmas, P. D., & Christiansen, C. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0603-5 · Cited by 28

Vertebral Imaging in the Diagnosis of Osteoporosis: a Clinician’s Perspective

Chou, S. H.-H., & LeBoff, M. S. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0404-x · Cited by 28

Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained

Eastell, R., Black, D. M., Lui, L., Chines, A. A., Marín, F., Khosla, S., de Papp, A. E., Cauley, J. A., Mitlak, B., McCulloch, C. E., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4178 · Cited by 27

An integrated approach: bisphosphonate management for the treatment of osteoporosis.

Owens, G. M., Jackson, R. D., & Lewiecki, E. M. (2007) · PubMed · Cited by 28

New Concepts in Bone Remodeling

Dempster, D., & Zhou, H. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0236 · Cited by 28

The pathophysiology of bone loss

Dempster, D. W. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00098-8 · Cited by 28

Monitoring osteoporosis therapies

Miller, P. D. (2007) · Current Osteoporosis Reports · doi:10.1007/bf02938621 · Cited by 27

Monitoring Changes in Bone Density

Bonnick, S. L. (2008) · Women s Health · doi:10.2217/17455057.4.1.89 · Cited by 28

Is There a Place for Bone Turnover Markers in the Assessment of Osteoporosis and its Treatment?

Devogelaer, J., Boutsen, Y., Gruson, D., & Manicourt, D. H. (2011) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2011.07.002 · Cited by 27

Preservation of thoracic spine microarchitecture by alendronate: Comparison of histology and microCT

Hordon, L. D., Itoda, M., Shore, P. A., Shore, R. F., Heald, M., Brown, M., Kanis, J. A., Rodan, G. A., & Aaron, J. E. (2005) · Bone · doi:10.1016/j.bone.2005.09.020 · Cited by 27

Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy

Greenspan, S. L., Perera, S., Recker, R. R., Wagner, J. M., Greeley, P., Gomberg, B. R., Seaman, P., & Kleerekoper, M. (2010) · Bone · doi:10.1016/j.bone.2009.12.025 · Cited by 30

The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis

Yan, Y., Wang, W., Zhu, H.-M., Li, M., Liu, J., Bangyao, L., Xie, H., Zhang, G., & Li, F. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0057-7 · Cited by 27

An update on bisphosphonates

Cohen, S. B. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0084-2 · Cited by 27

Effect of sequential treatments with alendronate, parathyroid hormone (1–34) and raloxifene on cortical bone mass and strength in ovariectomized rats

Amugongo, S. K., Yao, W., Jia, J., Dai, W., Lay, Y.-A. E., Jiang, L., Harvey, D. J., Zimmermann, E. A., Schaible, E. G., Dave, N. K. N., et al. (2014) · Bone · doi:10.1016/j.bone.2014.04.033 · Cited by 26

Internet of Medical Things (IoMT) Assisted Vertebral Tumor Prediction Using Heuristic Hock Transformation Based Gautschi Model–A Numerical Approach

Fouad, H., Hassanein, A. S., Soliman, A. M., & Al-Feel, H. (2020) · IEEE Access · doi:10.1109/access.2020.2966272 · Cited by 26

Vertebral fracture risk and alendronate effects on osteoporosis assessed by a computed tomography-based nonlinear finite element method

Imai, K. (2011) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-011-0281-9 · Cited by 26

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women

Bruyère, O., Roces-Varela, A., Adami, S., Detilleux, J., Rabenda, V., Hiligsmann, M., & Reginster, J. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9381-4 · Cited by 26

Patient willingness to take teriparatide

Fraenkel, L., Gulanski, B., & Wittink, D. R. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.08.004 · Cited by 26

Is the Use of Placebo Controls Ethically Permissible in Clinical Trials of Agents Intended to Reduce Fractures in Osteoporosis?

Brody, B. A., Dickey, N. W., Ellenberg, S. S., Heaney, R. P., Levine, R. J., O'brien, R. L., Purtilo, R., & Weijer, C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1105 · Cited by 26

Benefits and Limitations of Bone Mineral Density and Bone Turnover Markers to Monitor Patients Treated for Osteoporosis

Lewiecki, E. M. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0004-5 · Cited by 26

Bisphosphonates for osteoporosis in primary biliary cirrhosis

Rudić, J. S., Giljača, V., Krstic, M. N., Bjelaković, G., & Gluud, C. N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009144.pub2 · Cited by 26

Limited Trabecular Bone Density Heterogeneity in the Human Skeleton

Chirchir, H. (2016) · Anatomy Research International · doi:10.1155/2016/9295383 · Cited by 25

Interrelationships Between Bone Microarchitecture and Strength in Ovariectomized Monkeys Treated With Teriparatide

Chen, P., Jerome, C. P., Burr, D. B., Turner, C. H., Ma, Y. L., Rana, A. E., & Sato, M. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070310 · Cited by 25

Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation

Harvey, N. C., Al‐Daghri, N. M., Beaudart, C., Brandi, M. L., Burlet, N., Campusano, C., Cavalier, E., Chandran, M., Cooper, C. C., Dawson-Hughes, B. F., et al. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07628-5 · Cited by 26

Adiponectin and osteocalcin: relation to insulin sensitivity

Zhang, Y., Zhou, P., & Kimondo, J. W. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-022 · Cited by 24

Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass

Amugongo, S. K., Yao, W., Jia, J., Lay, Y.-A. E., Dai, W., Jiang, L., Walsh, D. A., Li, C., Dave, N. K. N., Olivera, D. L., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2678-5 · Cited by 24

Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis

Sanad, Z. F., Ellakwa, H., & Desouky, B. (2011) · Climacteric · doi:10.3109/13697137.2010.537408 · Cited by 24

A new tool to assess the mechanical properties of bone due to collagen degradation

Wynnyckyj, C., Omelon, S. J., Savage, K. N., Damani, M., Chachra, D., & Grynpas, M. D. (2008) · Bone · doi:10.1016/j.bone.2008.12.014 · Cited by 24

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

Miller, P. D. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.12.2253 · Cited by 24

Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Bresson, J., Flynn, A., Heinonen, M., Hulshof, K. F. A. M., Korhonen, H. J. T., Marchelli, R., Martin, A., Moseley, B. E. B., Przyrembel, H., Salminen, S., et al. (2008) · Cited by 24

Interaction of Science, Consumer Practices and Policy: Calcium and Bone Health as a Case Study

Looker, A. C. (2003) · Journal of Nutrition · doi:10.1093/jn/133.6.1987s · Cited by 24

The role of teriparatide in sequential and combination therapy of osteoporosis

Meier, C., Lamy, O., Krieg, M., Mellinghoff, H.-U., Felder, M., Ferrari, S., & Rizzoli, R. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13952 · Cited by 23

Relationship between Osteopontin and Bone Mineral Density

Vancea, A. (2021) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2021.509 · Cited by 23

Monitoring strontium ranelate therapy in patients with osteoporosis

Kendler, D. L., Adachi, J. D., Josse, R. G., & Slosman, D. O. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0886-1 · Cited by 23

Exploring the Relationship Between Surrogates and Clinical Outcomes: Analysis of Individual Patient Data vs. Meta-regression on Group-Level Summary Statistics

Li, Z., & Meredith, M. P. (2003) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-120024209 · Cited by 23

Treatment of postmenopausal osteoporosis

Cranney, A. (2003) · BMJ · doi:10.1136/bmj.327.7411.355 · Cited by 23

Bone health: Quality versus quantity

Docaj, A., & Carriero, A. (2024) · Journal of the Pediatric Orthopaedic Society of North America · doi:10.1016/j.jposna.2024.100054 · Cited by 22

Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women

Tseng, L., Sheu, W. H., Ho, E. S., Lan, H. H.-C., Hu, C.-C., & Kao, C. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.008 · Cited by 22

Importance of Calcium

Tandoğan, B., & Ulusu, N. N. (2005) · DergiPark (Istanbul University) · Cited by 22

Relationships Between Changes in Bone Mineral Density or Bone Turnover Markers and Vertebral Fracture Incidence in Patients Treated with Bazedoxifene

Bruyère, O., Detilleux, J. C., Chines, A. A., & Reginster, J. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9629-y · Cited by 22

Assessing Fracture Risk and Effects of Osteoporosis Drugs: Bone Mineral Density and Beyond

Davison, K. S., Kendler, D. L., Ammann, P., Bauer, D. C., Dempster, D. W., Dian, L., Hanley, D. A., Harris, S. T., McClung, M. R., Olszynski, W. P., et al. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.018 · Cited by 22

A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover

Eswaran, S. K., Allen, M. R., Burr, D. B., & Keaveny, T. M. (2007) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2007.05.013 · Cited by 22

Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis

Sarıoğlu, M., Tüzün, Ç., Ünlü, Z., Tıkız, C., Taneli, F., & Uyanık, B. S. (2004) · Rheumatology International · doi:10.1007/s00296-004-0544-z · Cited by 22

Monitoring bone mineral density during antiresorptive treatment for osteoporosis

Compston, J. (2009) · BMJ · doi:10.1136/bmj.b1276 · Cited by 22

Cost Effectiveness of Screen-and-Treat Strategies for Low Bone Mineral Density

Schousboe, J. T. (2008) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200806010-00001 · Cited by 21

High resolution peripheral quantitative computed tomography for the assessment of morphological and mechanical bone parameters

Fuller, H., Fuller, R., & Pereira, R. M. R. (2015) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2014.07.010 · Cited by 21

Treatment of Postmenopausal Osteoporosis

Greenblatt, D. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.4.574.61031 · Cited by 21

Mechanical loading prevents bone destruction and exerts anti-tumor effects in the MOPC315.BM.Luc model of myeloma bone disease

Rummler, M., Ziouti, F., Bouchard, A. L., Brandl, A., Duda, G. N., Bogen, B., Beilhack, A., Lynch, M. E., Jundt, F., & Willie, B. M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.10.041 · Cited by 24

Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.

Felsenberg, D., Bock, O., Börst, H., Armbrecht, G., Beller, G., Degner, C., Stephan-Oelkers, M., Schacht, E., Mazor, Z., Hashimoto, J., et al. (2011) · PubMed · Cited by 20

Monitoring of osteoporosis therapy

Bruyère, O., & Reginster, J. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.07.001 · Cited by 24

Osteoporosis and the general dental practitioner: reliability of some digital dental radiological measures

Geraets, W. G. M., Verheij, J. G. C., van der Stelt, P. F., Horner, K., Lindh, C., Nicopoulou‐Karayianni, K., Jacobs, R., & Devlin, H. (2007) · Community Dentistry And Oral Epidemiology · doi:10.1111/j.1600-0528.2006.00357.x · Cited by 20

Investigation of bone matrix composition, architecture and mechanical properties reflect structure-function relationship of cortical bone in glucocorticoid induced osteoporosis

Xi, L., Song, Y., Wu, W., Qu, Z., Wen, J., Liao, B., Tao, R., Ge, J., & Fang, D. (2020) · Bone · doi:10.1016/j.bone.2020.115334 · Cited by 20

Bone mineral density—clinical use and application

Miller, P. D. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00086-5 · Cited by 20

Mechanical competence of ovariectomy-induced compromised bone after single or combined treatment with high-frequency loading and bisphosphonates

Camargos, G. D. V., Bhattacharya, P., van Lenthe, H., Cury, A. A. D. B., Naert, I. E., Duyck, J. A. J., & Vandamme, K. (2015) · Scientific Reports · doi:10.1038/srep10795 · Cited by 20

Parathyroid hormone as a therapeutic agent

Mitlak, B. H. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00208-4 · Cited by 20

The need for microsimulation to evaluate osteoporosis interventions

Vanness, D. J., Tosteson, A. N. A., Gabriel, S. E., & Melton, L. J. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1826-8 · Cited by 20

Bisphosphonates

McClung, M. R. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400018 · Cited by 20

Examining the role of cannabinoids on osteoporosis: a review

Clouse, G., Penman, S. L., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01190-x · Cited by 19

A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

Belaya, Z. E., Rozhinskaya, L. Y., Dedov, I. I., Drapkina, O. M., Fadeev, V. V., Golounina, O. O., Lesnyak, O. M., Mamedova, E., Mel'nichenko, G. A., Petraikin, A. V., et al. (2023) · Osteoporosis International · doi:10.1007/s00198-022-06667-6 · Cited by 24

The influence of orthopedic corsets on the incidence of pathological fractures in patients with spinal bone metastases after radiotherapy

Rief, H., Forster, R. E., Rieken, S., Bruckner, T. M., Schlampp, I., Bostel, T., & Debus, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1797-5 · Cited by 19

Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats

Uyar, Y., BAYTUR, Y. B., Inceboz, U. S., Demir, B. Ç., Gümüşer, G., & Özbilgin, K. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.018 · Cited by 19

Anti-resorptive agents reduce the size of resorption cavities: A three-dimensional dynamic bone histomorphometry study

Matheny, J. B., Slyfield, C. R., Tkachenko, E. V., Lin, I., Ehlert, K. M., Tomlinson, R. E., Wilson, D. L., & Hernandez, C. J. (2013) · Bone · doi:10.1016/j.bone.2013.08.018 · Cited by 19

What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?

Sawka, A. M., Adachi, J. D., Ioannidis, G., Olszynski, W. P., Brown, J. P., Hanley, D. A., Murray, T. M., Josse, R. G., Sebaldt, R. J., Petrie, A., et al. (2003) · Journal of Clinical Densitometry · doi:10.1385/jcd:6:4:315 · Cited by 19

Treating Osteoporosis with Bisphosphonates and Addressing Adherence

Chesnut, C. H. (2006) · Drugs · doi:10.2165/00003495-200666100-00004 · Cited by 19

Review of Treatment Modalities for Postmenopausal Osteoporosis

Hamdy, R. C., Chesnut, C. H., Gass, M. L. S., Holick, M. F., Leib, E. S., Lewiecki, M. E., Maricic, M. J., & Watts, N. B. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000184921.53062.bf · Cited by 19

Updated systematic review

Raftery, J. P., Hanney, S. R., Greenhalgh, T., Glover, M. J., & Blatch-Jones, A. (2016) · Cited by 17

Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis

Takada, J., Katahira, G., Iba, K., Yoshizaki, T., & Yamashita, T. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0242-8 · Cited by 18

Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

Rhee, Y., Kang, M. I., Min, Y., Byun, D. W., Chung, Y., Ahn, C. W., Baek, K., Mok, J., Kim, D. J., Kim, D. J., et al. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0200-4 · Cited by 18

Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats

Stern, A. R., Yao, X., Wang, Y., Berhe, A., Dallas, M., Johnson, M. L., Yao, W., Kimmel, D. B., & Lane, N. E. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.02.005 · Cited by 17

Bone density, bone quality, and FRAX: changing concepts in osteoporosis management

Licata, A. A. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.874 · Cited by 18

Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide

Tanaka, S., Kuroda, T., Sugimoto, T., Nakamura, T., & Shiraki, M. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.879440 · Cited by 18

Choice of study phenotype in osteoporosis genetic research

Chen, Y., Shen, H., Yang, F., Liu, P.-Y., Tang, N. L. S., Recker, R. R., & Deng, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0020-z · Cited by 18

The effect of sequential therapy for postmenopausal women with osteoporosis

Lou, S., Lv, H., Wang, G., Li, Z., Li, M., Zhang, L., & Tang, P. (2016) · Medicine · doi:10.1097/md.0000000000005496 · Cited by 18

How drugs decrease fracture risk: lessons from trials.

Cummings (2002) · PubMed · Cited by 31

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

Chapurlat, R. D., Palermo, L., Ramsay, P., & Cummings, S. R. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1770-7 · Cited by 133

The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation

Gabriel, S. E., Espy, M. J., Erdman, D. D., Björnsson, J., Smith, T. F. A., & Hunder, G. G. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6 · Cited by 156

Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate

Watts, N. B., Cooper, C. C., Lindsay, R., Eastell, R., Manhart, M. D., Barton, I. P., van Staa, T. P., & Adachi, J. D. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:3:255 · Cited by 228

OP0113 Increases in bone mineral density explain the reduction in incidence of nonvertebral fractures seen with antiresorptive therapy in women with postmenopausal osteoporosis

Wasnich, R. D., Mc, H., Greenspan, S. L., Ross, P., & Miller, P. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2001.634